Support and scanning of DNA samples from the asialymph study - 2056 samples
Ended Purchase Order Awarded
- Contract number
- HHSN261201600713P
- Awardee
-
Gene Square Bio-Technology LTD. UEI P2TKEBPJJ5N1
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $139,808
Award facts
- Opportunity
-
- N02CP6266888 Solicitation number
- Contract value 100% obligated
- $139,808.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award with ID HHSN261201600713P was issued by the National Cancer Institute, a civilian agency, to Gene Square Bio-Technology LTD., a for-profit limited liability company, to provide support and scanning of DNA samples from the ASIALYMPH study. The contract has a firm fixed price of $139,808.00 and an ultimate completion date of September 15, 2017. The contract was awarded on September 16, 2016 and was not set aside for any specific business type.
Quick answers
Who was awarded contract HHSN261201600713P?
HHSN261201600713P was awarded to Gene Square Bio-Technology LTD. by National Cancer Institute (National Institutes of Health) on September 16, 2016.
How much is contract HHSN261201600713P worth?
The government has obligated $139,808 on HHSN261201600713P.
Was contract HHSN261201600713P competed?
The extent of competition for HHSN261201600713P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award